Casdin Partners Master Fund, L.P. is Director of Absci Corp. Currently has a direct ownership of 6.75 Million shares of ABSI, which is worth approximately $20.2 Million. The most recent transaction as insider was on Jul 26, 2021, when has been sold 1,562,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $25,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.75M
0% 3M change
0% 12M change
Total Value Held $20.2 Million

Casdin Partners Master Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 26 2021
BUY
Open market or private purchase
$25,000,000 $16.0 p/Share
1,562,500 Added 18.81%
6,745,333 Common Stock
Jul 26 2021
BUY
Conversion of derivative security
-
5,182,833 Added 50.0%
5,182,833 Common Stock

Also insider at

BLFS
BIOLIFE SOLUTIONS INC Healthcare
DBTX
Decibel Therapeutics, Inc. Healthcare
VERV
Verve Therapeutics, Inc. Healthcare
MXCT
MAXCYTE, INC. Healthcare
TNYA
Tenaya Therapeutics, Inc. Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
CPM

Casdin Partners Master Fund, L.P.

Director
New York, NY

Track Institutional and Insider Activities on ABSI

Follow Absci Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABSI shares.

Notify only if

Insider Trading

Get notified when an Absci Corp insider buys or sells ABSI shares.

Notify only if

News

Receive news related to Absci Corp

Track Activities on ABSI